M
Maria-Panagiota Almyroudi
Researcher at National and Kapodistrian University of Athens
Publications - 7
Citations - 131
Maria-Panagiota Almyroudi is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications receiving 56 citations.
Papers
More filters
Journal ArticleDOI
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
Matteo Bassetti,Matteo Bassetti,Daniele Roberto Giacobbe,Antonio Vena,Cecilia Trucchi,Filippo Ansaldi,Massimo Antonelli,Vaclava Adamkova,Cristiano Alicino,Maria-Panagiota Almyroudi,Enora Atchade,Anna Maria Azzini,Novella Carannante,Alessia Carnelutti,Silvia Corcione,Andrea Cortegiani,George Dimopoulos,Simon Dubler,Jose Luis Garcia-Garmendia,Massimo Girardis,Oliver A. Cornely,Stefano Ianniruberto,Bart Jan Kullberg,Katrien Lagrou,Clément Le Bihan,Roberto Luzzati,Manu L N G Malbrain,Maria Merelli,Ana J Marques,Ignacio Martin-Loeches,Alessio Mesini,José Artur Paiva,Maddalena Peghin,Santi Maurizio Raineri,Riina Rautemaa-Richardson,Jeroen Schouten,Pierluigi Brugnaro,Herbert D. Spapen,Polychronis Tasioudis,Jean-François Timsit,Valentino Tisa,Mario Tumbarello,Charlotte H S B van den Berg,Benoit Veber,Mario Venditti,Guillaume Voiriot,Joost Wauters,Philippe Montravers +47 more
TL;DR: The cumulative incidence of IC in 23 European ICUs was 7.07 episodes per 1000 ICU admissions, with important between-center variability, with the ultimate aim of helping to improve local infection control and antifungal stewardship projects and interventions.
Journal ArticleDOI
COVID-19-associated pulmonary aspergillosis (CAPA)
TL;DR: Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality.
Journal ArticleDOI
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
TL;DR: A literature search until 14 July 2022, with the aim of updating COVID-19-associated mucormycosis (CAM), identified 663 studies and 88 met inclusion criteria (8727 patients) as mentioned in this paper .
Journal ArticleDOI
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
Matteo Bassetti,Antonio Vena,Daniele Roberto Giacobbe,Cecilia Trucchi,Filippo Ansaldi,Massimo Antonelli,Václava Adámková,Cristiano Alicino,Maria-Panagiota Almyroudi,Enora Atchade,Anna Maria Azzini,Pierluigi Brugnaro,Novella Carannante,Maddalena Peghin,Marco Berruti,Alessia Carnelutti,Nadia Castaldo,Silvia Corcione,Andrea Cortegiani,George Dimopoulos,Simon Dubler,Jose Luis García-Garmendía,Massimo Girardis,Oliver A. Cornely,Stefano Ianniruberto,Bart Jan Kullberg,Katrien Lagrou,C. Lebihan,Roberto Luzzati,Manu L N G Malbrain,Maria Merelli,Ana J Marques,Ignacio Martin-Loeches,Alessio Mesini,José Artur Paiva,Santi Maurizio Raineri,Riina Rautemaa-Richardson,Jeroen Schouten,Herbert D. Spapen,Polychronis Tasioudis,Jean-François Timsit,Valentino Tisa,Mario Tumbarello,Charlotte H S B van den Berg,Benoit Veber,Mario Venditti,Guillaume Voiriot,Joost Wauters,Nathalie Zappella,Philippe Montravers +49 more
TL;DR: In this article , risk factors for the development of intra-abdominal candidiasis (IAC) among patients admitted to ICU were assessed. But, the authors did not identify which patients will benefit from early antifungal treatment.
Journal ArticleDOI
The impact of age on intensive care
Karolina Akinosoglou,Georgios Schinas,Maria-Panagiota Almyroudi,Christos Gogos,George Dimopoulos +4 more
TL;DR: In this paper , the authors proposed to tailor safe treatment plans to match patients' wishes, and personalized needs will guide critical care for the elderly from this time forward, which can improve long-term outcomes and subsequent quality of life.